124I-Epidepride: A PET radiotracer for extended imaging of dopamine D2/D3 receptors

Nuclear Medicine and Biology

Volumn 41, Issue 5, 2014, Pages 426-431

  Pandey, Suresh ^a   Venugopal, Archana ^a   Kant, Ritu ^a   Coleman, Robert ^a   Mukherjee, Jogeshwar ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dopamine D2 3 receptor; Epidepride; Fallypride; Iodine 124

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; HALOPERIDOL; INSULIN; IODINE EPIDEPRIDE I 124; TRACER; UNCLASSIFIED DRUG; BENZAMIDE DERIVATIVE; EPIDEPRIDE; PYRROLIDINE DERIVATIVE; RADIOACTIVE IODINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BRAIN SCINTISCANNING; BRAIN SLICE; CORPUS STRIATUM; HALF LIFE TIME; MALE; NON INVASIVE MEASUREMENT; NONHUMAN; PANCREAS ISLET CELL; POSITRON EMISSION TOMOGRAPHY; RADIOCHEMISTRY; RADIOISOTOPE DISTRIBUTION; RAT; RECEPTOR BINDING; ANIMAL; CHEMISTRY; DIAGNOSTIC USE; METABOLISM; PANCREAS ISLET; PROCEDURES; SCINTISCANNING;

ANIMALS; BENZAMIDES; IODINE RADIOISOTOPES; ISLETS OF LANGERHANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RADIOACTIVE TRACERS; RADIOCHEMISTRY; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3;

EID: 84898817338     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2014.01.011     Document Type: Article

References (15)

1. Rubí B., Ljubicic S., Pournourmohammadi S., et al. Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion. J Biol Chem 2005, 280:36824-36832.
2. 18F-Fallypride PET of pancreatic islets: in vitro and in vivo rodent studies. J Nucl Med 2011, 52:1125-1132.
3. 18F-Fallypride in normal volunteers: blood analysis, distribution, test-retest studies and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors. Synapse 2002, 46:170-188.
4. Yu A.R., Kim J.S., Kim K.M., Lee Y.S., Woo S.K., Lee W.H., et al. Optimal PET acquisition setting of 1-124 with Siemens Inveon PET: comparative simulation study with F-18 and microPET R4 2009, IEEE NSS MIC Conf, Rec.
5. de Paulis T. The discovery of epidepride and its analogs as high-affinity radioligands for imaging extrastriatal dopamine D2 receptors in human brain. Curr Pharm Des 2003, 9:673-696.
6. Fagerlund B., Pinborg L.H., Mortensen E.L., Friberg L., Baaré W.F., Gade A., et al. Relationship of frontal D2/3 binding potentials to cognition: a study of antipsychotic-naive schizophrenia patients. Int J Neuropsychopharmacol 2012, 16:1-14.
7. Barth V., Need A.B., Tzavara E.T., Giros B., Overshiner C., Gleason S.D., et al. In vivo occupancy of dopamine D3 receptors by antagonists produces neurochemical and behavioral effects of potential relevance to attention-deficit-hyperactivity disorder. J Pharmacol Exp Ther 2013, 344(2):501-510.
8. Van Laere K., Varrone A., Booij J., et al. EANM procedure guidelines for brain transmission SPECT/PET using dopamine D2 receptor ligands, version 2. Eur J Nucl Med Mol Imaging 2010, 37:434-442.
9. Wu Z., Kandeel F. Radionuclide probes for molecular imaging of pancreatic beta-cells. Adv Drug Deliv Rev 2010, 62:1125-1138.
10. Sweet I.R., Cook D.L., Lernmark A., et al. Systemic screening of potential b-cell imaging agents. Biochem Biophys Res Commun 2004, 314:976-983.
11. Clanton J.A., de Paulis T., Schmidt D.E., Ansari M.S., Manning R.G., Baldwin R.M., et al. Preparation of 123I-and 125I-epidepride: a dopamine D-2 receptor antagonist radioligand. J Label Compd Radiopharm 1991, 29:745-751.
12. Kessler R.M., Ansari M.S., Schmidt D.E., de Paulis T., Clanton J.A., Innis R., et al. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors. Life Sci 1991, 49(8):617-628.
13. Mukherjee J., Yang Z.Y., Brown T., et al. Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and non-human primate brains using the high affinity radioligand, [F-18]fallypride. Nucl Med Biol 1999, 26:519-527.
14. Shankar E., Santosh K.T., Paulose C.S. Dopaminergic regulation of glucose-induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro. IUBMB Life 2006, 58:157-163.
15. Liz Z.S., Schmauss C., Cuenca A., Ratcliffe E., Gershon M.D. Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice. J Neurosci 2006, 26(10):2798-2807.